SEC Form 4 · accession 0001410471-15-000093

IPC Healthcare, Inc. · IPCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 23, 2015

Accepted (ET)

Nov 25, 2015 · 9:41 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001410471

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Nov 23, 2015	U	1,748	$80.25	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Restricted Stock Units^F1	—	Nov 23, 2015	D	1,102	D	—	—	Common Stock	1,102	D
Restricted Stock Units^F1	—	Nov 23, 2015	D	940	D	—	—	Common Stock	940	D
Restricted Stock Units^F2	—	Nov 23, 2015	D	2,186	D	—	—	Common Stock	2,186	D
Stock Option (Rgiht to Buy)^F3	$40.99	Nov 23, 2015	D	3,501	D	—	Jan 3, 2021	Common Stock	3,501	D
Stock Option (Rgiht to Buy)^F3	$51.94	Nov 23, 2015	D	2,250	D	—	Jul 22, 2021	Common Stock	2,250	D
Stock Option (Rgiht to Buy)^F3	$45.94	Nov 23, 2015	D	4,500	D	—	Jan 3, 2022	Common Stock	4,500	D
Stock Option (Right-to-Buy)^F3	$40.84	Nov 23, 2015	D	3,250	D	—	Jan 2, 2020	Common Stock	3,250	D
Stock Option (Right-to-Buy)^F3	$58.50	Nov 23, 2015	D	2,650	D	—	Jan 2, 2021	Common Stock	2,650	D

F1These Restricted Stock Units ("RSUs) were fully vested and cancelled pursuant to the Agreement and Plan of Merger, dated as of August 4, 2015, among the issuer Team Health Holdings, Inc. (TMH), and IPC Healthcare, Inc. (the Merger Agreement), in exchange for a cash amount equal to the per share merger consideration of $80.25 (the Merger Consideration") multiplied by number of shares of the issuers common stock ("Shares") subject to such RSUs.
F2These RSUS, which were scheduled to vest on or prior to January 2, 2016, were fully vested and cancelled pursuant to Merger Agreement, in exchange for a cash amount equal to the Merger Consideration multiplied by number of Shares subject to such RSUs.
F3These Options were fully vested and cancelled pursuant to Merger Agreement, in exchange for a cash amount equal to the product of (A) the number of Shares subject to such option and (B) the excess, if any, of the Merger Consideration over the exercise price per Share subject to such option.